These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30646820)

  • 1. The Prion 2018 round tables (II): Aβ, tau, α-synuclein… are they prions, prion-like proteins, or what?
    Eraña H
    Prion; 2019 Jan; 13(1):41-45. PubMed ID: 30646820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of yeast to studying amyloid and prion diseases.
    Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
    Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding spectrum of prion diseases.
    Ayers JI; Paras NA; Prusiner SB
    Emerg Top Life Sci; 2020 Sep; 4(2):155-167. PubMed ID: 32803268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion-like disorders: blurring the divide between transmissibility and infectivity.
    Cushman M; Johnson BS; King OD; Gitler AD; Shorter J
    J Cell Sci; 2010 Apr; 123(Pt 8):1191-201. PubMed ID: 20356930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
    Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
    PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of crowded physiological environments in prion and prion-like protein aggregation.
    Ma Q; Hu JY; Chen J; Liang Y
    Int J Mol Sci; 2013 Oct; 14(11):21339-52. PubMed ID: 24284393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion-like features of misfolded Aβ and tau aggregates.
    Morales R; Callegari K; Soto C
    Virus Res; 2015 Sep; 207():106-12. PubMed ID: 25575736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expanding realm of prion phenomena in neurodegenerative disease.
    Frost B; Diamond MI
    Prion; 2009; 3(2):74-7. PubMed ID: 19448400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prions, prion-like prionoids, and neurodegenerative disorders.
    Verma A
    Ann Indian Acad Neurol; 2016; 19(2):169-74. PubMed ID: 27293325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propagation of Aβ, tau and α-synuclein pathology between experimental models and human reality: prions, propagons and propaganda.
    Uchihara T; Giasson BI; Paulus W
    Acta Neuropathol; 2016 Jan; 131(1):1-3. PubMed ID: 26715564
    [No Abstract]   [Full Text] [Related]  

  • 12. Prion-like mechanisms in neurodegenerative diseases.
    Frost B; Diamond MI
    Nat Rev Neurosci; 2010 Mar; 11(3):155-9. PubMed ID: 20029438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions, prionoid complexes and amyloids: the bad, the good and something in between.
    Hafner Bratkovič I
    Swiss Med Wkly; 2017; 147():w14424. PubMed ID: 28421568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cellular prion protein in interneuronal amyloid transmission.
    Del Río JA; Ferrer I; Gavín R
    Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.
    Holmes BB; Diamond MI
    J Biol Chem; 2014 Jul; 289(29):19855-61. PubMed ID: 24860099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propagation of prions causing synucleinopathies in cultured cells.
    Woerman AL; Stöhr J; Aoyagi A; Rampersaud R; Krejciova Z; Watts JC; Ohyama T; Patel S; Widjaja K; Oehler A; Sanders DW; Diamond MI; Seeley WW; Middleton LT; Gentleman SM; Mordes DA; Südhof TC; Giles K; Prusiner SB
    Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4949-58. PubMed ID: 26286986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins.
    Corbett GT; Wang Z; Hong W; Colom-Cadena M; Rose J; Liao M; Asfaw A; Hall TC; Ding L; DeSousa A; Frosch MP; Collinge J; Harris DA; Perkinton MS; Spires-Jones TL; Young-Pearse TL; Billinton A; Walsh DM
    Acta Neuropathol; 2020 Mar; 139(3):503-526. PubMed ID: 31853635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prions and Non-infectious Amyloids of Mammals - Similarities and Differences.
    Galkin AP; Velizhanina ME; Sopova YV; Shenfeld AA; Zadorsky SP
    Biochemistry (Mosc); 2018 Oct; 83(10):1184-1195. PubMed ID: 30472956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases.
    Victoria GS; Zurzolo C
    Virus Res; 2015 Sep; 207():146-54. PubMed ID: 25645281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.